EichorEICHOR
Condition: Stage Iiia Breast Cancer Ajcc V7 Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Stage Iiia Breast Cancer Ajcc V7

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Phase 2 · 1 location(s) · Vandana Abramson · NCT07016399Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05417308Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagn
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02918474Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · 846 location(s) · Alliance for Clinical Trials in Oncology · NCT05812807Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01000883Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Phase 3 · 963 location(s) · SWOG Cancer Research Network · NCT05929768Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribocic
Phase 3 · 116 location(s) · National Cancer Institute (NCI) · NCT07391774Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Breast Cancer, Reasoning, and Activity Intervention
NA · 1 location(s) · Mayo Clinic · NCT04816006Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04090567Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Canc
Phase 1 · 4 location(s) · Emory University · NCT06324240Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Phase N/A · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT00899301Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Phase 3 · 2 location(s) · Alliance for Clinical Trials in Oncology · NCT05379153
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.